Profile
Christopher Clark worked as Finance Director at Disani Capital Corp.
from 2004 to 2005.
Mr. Clark worked as Finance Director at Mr. Lube Canada LP from 2005 to 2007.
Mr. Clark worked as Chief Financial Officer & Secretary at Neovasc, Inc. from 2014 to 2023.
Mr. Clark worked as Director at Aequus Pharmaceuticals, Inc. from 2014 to 2025.
Mr. Clark worked as Chief Financial Officer at Medical Ventures Corp.
Mr. Clark completed undergraduate studies at Swansea University.
Former positions of Christopher Clark
| Companies | Position | End |
|---|---|---|
| AEQUUS PHARMACEUTICALS INC. | Director/Board Member | 2025-04-24 |
| NEOVASC INC. | Director of Finance/CFO | 2023-03-31 |
Medical Ventures Corp.
Medical Ventures Corp. Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes medical devices; researches and develops commercialization of medical equipments | Director of Finance/CFO | 2008-07-01 |
Mr. Lube Canada LP
Mr. Lube Canada LP Other Consumer ServicesConsumer Services Provides automotive maintenance services | Director of Finance/CFO | 2006-12-31 |
Disani Capital Corp.
Disani Capital Corp. Financial ConglomeratesFinance Engages in the evaluation of new business opportunities | Director of Finance/CFO | 2004-12-31 |
Training of Christopher Clark
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Medical Ventures Corp.
Medical Ventures Corp. Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes medical devices; researches and develops commercialization of medical equipments | Electronic Technology |
Disani Capital Corp.
Disani Capital Corp. Financial ConglomeratesFinance Engages in the evaluation of new business opportunities | Finance |
Aequus Pharmaceuticals, Inc.
Aequus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of alternatives to currently approved drugs | Health Technology |
Swansea University
Swansea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neovasc, Inc.
Neovasc, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells devices for the treatment of cardiovascular & refractory angina problems | Health Technology |
Mr. Lube Canada LP
Mr. Lube Canada LP Other Consumer ServicesConsumer Services Provides automotive maintenance services | Consumer Services |
- Stock Market
- Insiders
- Christopher Clark
















